← Contracts
PT
Ajuste direto para aquisição de A53311- Acalabrutinib [100 mg; cáp/comp]
ID 11290841
· Portal BASE
Price
Base Price
€1,260,138
.00
Effective Price
€42,428
.00
-96.6%
Contract Details
- Contract Type
- Aquisição de bens móveis
- Procedure
- Ajuste Direto Regime Geral
- CPV Code
- 33600000
- Location
- Portugal, Porto, Porto
- Bidder Count
- 1
Winner
ASTRAZENECA - PRODUTOS FARMACÊUTICOS LDA
NIF 502942240
Competition
1 bidder recorded
ASTRAZENECA - PRODUTOS FARMACÊUTICOS LDA
NIF 502942240
Dates
- Publication
- 18 Mar 2025
- Celebration
- 20 Jan 2025
Contracting Entity
Instituto Português de Oncologia do Porto Francisco Gentil, E. P. E.
NIF 506362299
Public body
Data Source
Portal BASE
Api
· synced 2026-04-17
Risk Flags
Score 70 · HIGH RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
- Publication Date
- 18 Mar 2025
- Signing Date
- 20 Jan 2025
- Days Late
- 57
- Rule
- A2/A3 late publication: 57 days after signing (threshold: 10)
Detected 2026-03-06
A6 · Low Competition
A6_LOW_COMPETITION
- Rule
- a6_single_bidder
- Bidder count
- 1
Detected 2026-04-17
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
- Base price
- 1260138.0
- Total effective price
- 42428.0
- Ratio
- 0.0337
- Direction
- reduction
- Rule
- A9 price reduction: ratio 0.0337 outside [0.5, 1.5]
Detected 2026-03-06